Startup Venture

Unicircles Rank: 430
Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy
Allogene Therapeutics is a biotechnology company with a mission to catalyze the next revolution in cancer treatment through the development of allogeneic chimeric antigen receptor T-cell (CAR T) therapy directed at blood cancers and solid tumors. Allogeneic CAR T therapies are engineered from cells of healthy donors and stored for “off-the-shelf” use in patients. This approach eliminates the need to create personalized therapy from a patient’s own cells, simplifies manufacturing, and reduces the time patients must wait for CAR T treatment
Community Valuation
Not valued
Unicircles Rating:
    
(Ranked #430, 0 votes)
Industry Sector:
Public Services
Sector:
Biotech / Health Care
Growth Stage:
Not provided
Nearest Metro Area:
TEAM
Ambassadors

WE USE COOKIES TO ENHANCE YOUR EXPERIENCE
Unicircles uses cookies to personalize content, provide certain advanced features, and to analyze traffic. Per our privacy policy, we WILL NOT share information about your use of our site with social media, advertising, or analytics companies. If you continue using Unicircles by clicking below link, you agree to our use of Cookies while using Unicircles.
I AGREELearn more
x